Development and internal validation of a nomogram for predicting neoadjuvant therapy efficacy in breast cancer based on the HALP score

Jianping Long, Xiaoke Chai, Tao Zhang, Chongyi Wei, Tao Yang, Haicun Zhou, Xiufen Ma

Open source

DOI
10.21037/tcr-2026-0827
Published
2026-08
Container
Translational Cancer Research
Publisher
AME Publishing Company
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/tcr-2026-0827,
  title = {Development and internal validation of a nomogram for predicting neoadjuvant therapy efficacy in breast cancer based on the HALP score},
  author = {Jianping Long and Xiaoke Chai and Tao Zhang and Chongyi Wei and Tao Yang and Haicun Zhou and Xiufen Ma},
  year = {2026},
  journal = {Translational Cancer Research},
  doi = {10.21037/tcr-2026-0827},
  url = {https://doi.org/10.21037/tcr-2026-0827}
}

RIS

TY  - JOUR
TI  - Development and internal validation of a nomogram for predicting neoadjuvant therapy efficacy in breast cancer based on the HALP score
AU  - Jianping Long
AU  - Xiaoke Chai
AU  - Tao Zhang
AU  - Chongyi Wei
AU  - Tao Yang
AU  - Haicun Zhou
AU  - Xiufen Ma
PY  - 2026
JO  - Translational Cancer Research
DO  - 10.21037/tcr-2026-0827
UR  - https://doi.org/10.21037/tcr-2026-0827
ER  - 

APA

Long, J., Chai, X., Zhang, T., Wei, C., Yang, T., Zhou, H., & Ma, X. (2026). Development and internal validation of a nomogram for predicting neoadjuvant therapy efficacy in breast cancer based on the HALP score. Translational Cancer Research. https://doi.org/10.21037/tcr-2026-0827

Source records